This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While drugmakers have been assailed for years for increasing their prices and driving the cost of medications higher and higher, there is another player in the health care space that is receiving increased scrutiny: pharmacy benefit managers. Those rebates can be significant.
While drugmakers have been assailed for years for increasing their prices and driving the cost of medications higher and higher, there is another player in the health care space that is receiving increased scrutiny: pharmacy benefit managers. Those rebates can be significant.
Congress and other policymakers continue to seek opportunities to lower costs for patients and the federal government. Pharmacy benefit managers (PBMs) are a key stakeholder in the drug supply chain, functioning as intermediaries between insurance providers and pharmaceutical manufacturers. appeared first on EMPLOYEE BENEFITS BLOG.
” — Benefits executive at a manufacturing firm They didn’t want to be the first to jump out and completely disrupt their group health benefits offerings. “It would make workers feel like you were cutting and running.” “A big part was trepidation. Nobody wanted to be first.”
When you contact your homeowners’ insurance company, you find out that your policy doesn’t cover malfunctioning home appliances. Now you’re facing massive out-of-pocketcosts. How much do home appliances cost? As a result, you may have to pay for the cost of a new appliance yourself.
As part of the Consolidated Appropriations Act, 2021, group health plans and issuers must annually report to the Departments certain prescription drug and health care information, including but not limited to the: 50 most frequently dispensed brand prescription drugs and the total number of paid claims for each such drug; 50 most costly prescription (..)
And while breakthrough biologics command most spending on autoimmune conditions, it doesn’t mean all of them are cost-effective or should be on formulary. Creating an additional tier for specialty drugs — or even for biologics and biosimilars alone — can start to help control costs.
Insulin prices have increased 600 percent over the last 20 years causing many consumers to be at risk of non-adherence due to cost. 4 Solving the Affordability Issue – Legislation Influence The Inflation Reduction Act , a spending package Congress approved in 2022, capped insulin out-of-pocketcosts at $35 for Americans with Medicare.
On January 31, 2024, the US Centers for Medicare & Medicaid Services (CMS) released the Advance Notice of Methodological Changes for Calendar Year (CY) 2025 for Medicare Advantage (MA) Capitation Rates and Part C and D Payment Policies. CMS also released a press release and fact sheet.
And while consumers seem to have a love/hate relationship with HDHPs, many of those who take the time to fully calculate the total out-of-pocketcost of medical coverage and care realize that HDHPs, even with higher deductibles, can often save them money. Manufacturer coupons and rebates. Product substitutions.
Environmental liability insurance provides important coverage for contractors, manufacturers and other businesses that have environmental-related exposures. Without environmental coverage, you could face major out-of-pocketcosts. What is an environmental liability insurance policy? Who needs environmental insurance?
Judge Covey added that to interpret the MMA as the employer had suggested would undermine the General Assembly’s express intent to provide Pennsylvania citizens with access to the latest treatments safely available. 841(a), the carrier would not violate the Federal Drug Act, or be at risk of facing federal prosecution by doing so.
Employees, on the other hand, would probably prefer safe harbor #1, since they incur no immediate out-of-pocketcosts. Safe harbor #1 appears to be less desirable for insurers, since they’d have to do a lot more up-front work when compared to just cutting checks back to employees. One safe harbor, two options.
The impact of prescription drug rebates, fees and other compensation on premiums and out-of-pocketcosts. The Departments will issue biennial public reports on prescription drug pricing trends and the impact of prescription drug costs on premiums and out-of-pocketcosts starting in 2023. 27, 2022.
First, most non-grandfathered group health plans and health insurance issuers offering non-grandfathered health insurance coverage in the individual and group markets will be required to disclose personalized price and cost-sharing information to participants, beneficiaries and enrollees (or their authorized representatives).
The high courts ruling settles a long-running dispute that began when the claimanta workers compensation attorney appearing pro sesought reimbursement for the out-of-pocketcost of CBD oil recommended by his treating physician as a substitute for higher doses of opioid medication. LEXIS 389 (Mar. 20, 2025)].
Student Loans. Section 2206 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), enacted on March 27, 2020, expands the definition of educational assistance to include certain employer payments of student loans paid after March 27, 2020, and before January 1, 2021.
We organize all of the trending information in your field so you don't have to. Join 46,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content